S 3489
117th Congress
Senate
Health
Chemical and biological weapons
Department of Health and Human Services
Drug therapy
Emergency medical services and trauma care
Hazardous wastes and toxic substances
Health programs administration and funding
Health promotion and preventive care
Health technology, devices, supplies
Home and outpatient care
Infectious and parasitic diseases
Medical research
Medical tests and diagnostic methods
National Institutes of Health (NIH)
Nuclear weapons
Product development and innovation
Research administration and funding
Research and development
Scientific communication
A bill to establish or continue a multidisciplinary research program to advance the discovery and preclinical development of medical products for priority virus families and other viral pathogens with a significant potential to cause a pandemic, and for other purposes.
Introduced: January 12, 2022
See on congress.gov
Everywhere this bill has been
2 steps
Introduced
In committee
Reported out
Passed House
Passed Senate
To President
Became law
Jan 12, 2022
Read twice and referred to the Committee on Health, Education, Labor, and Pensions.
Jan 12, 2022
Introduced in Senate
Plain-English summary
This bill directs the National Institutes of Health (NIH) to support research on medical products for virus families and viral pathogens with pandemic potential.
Specifically, the NIH must establish or continue a multidisciplinary program for supporting research centers to advance the discovery and development of medical products to prevent, treat, and diagnose such viruses.
What's happening now
Read twice and referred to the Committee on Health, Education, Labor, and Pensions.
Committees of jurisdiction
1
Cosponsors
1